In this episode of the Motley Fool Scoreboard, expert analysts delve into the world of Summit Therapeutics (NASDAQ: SMMT), offering insights on market trends and investment opportunities. Stock prices used were from Sep. 17, 2025, and the video was published on Oct. 17, 2025. Should you invest $1,000 in Summit Therapeutics? Discover more with our contributing analysts. The Motley Fool Stock Advisor team has identified the 10 best stocks to buy right now, excluding Summit Therapeutics. These stocks could potentially yield significant returns, with an average outperformance of 1,032% compared to the S&P 500. Explore the top 10 list by joining Stock Advisor.

Read more at Nasdaq MarketSite: Summit Therapeutics: A Risky Bet in the Biotech Arena?